Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Tracey L. O'Connor"'
Autor:
Foluso O. Ademuyiwa, Wiam Bshara, Kristopher Attwood, Carl Morrison, Stephen B. Edge, Christine B. Ambrosone, Tracey L. O’Connor, Ellis G. Levine, Anthony Miliotto, Erika Ritter, Gerd Ritter, Sacha Gnjatic, Kunle Odunsi
Publikováno v:
PLoS ONE, Vol 7, Iss 8 (2012)
Externí odkaz:
https://doaj.org/article/46107ce1d5024b89b55733796e7caa3c
Autor:
Lauren Williams, Paul K Wallace, Pawel Kalinski, Mateusz Opyrchal, Kathleen M Kokolus, Shipra Gandhi, Kristopher Attwood, Agnieszka Witkiewicz, Hans Minderman, Kah Teong Soh, Melissa J Grimm, Ronald T Slomba, Adrienne Groman, Mary Lynne Tarquini, Orla Maguire, Tracey L O’Connor, Amy P Early, Ellis G Levine
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 11 (2023)
Background Presence of cytotoxic T lymphocytes (CTL) in the tumor microenvironment (TME) predicts the effectiveness of cancer immunotherapies. The ability of toll-like receptor 3 (TLR3) ligands, interferons (IFNs) and COX2 inhibitors to synergistical
Externí odkaz:
https://doaj.org/article/2d1ecf8be6c34222ae25dc9f47cf3dc6
Autor:
Temara Cross, Anthony George, Kristopher Attwood, Yali Zhang, Tracey L. O'Connor, Nancy Barone, Karen Hulme, Christine B. Ambrosone, Song Yao, Chi-Chen Hong
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 31:2126-2135
Background: Recent evidence suggests that vitamin D might lower breast cancer mortality. There is also growing interest in vitamin D's potential association with health-related quality-of-life (HRQoL). Associations between circulating 25-hydroxyvitam
Autor:
Chi-Chen Hong, Song Yao, Christine B. Ambrosone, Karen Hulme, Nancy Barone, Tracey L. O'Connor, Yali Zhang, Kristopher Attwood, Anthony George, Temara Cross
Supplementary Table from Associations between Serum 25-Hydroxyvitamin D Levels and Health-Related Quality-of-Life Measures in Patients with Breast Cancer: A Longitudinal Study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02938536ab137e38ed7a52ab62e0c732
https://doi.org/10.1158/1055-9965.23099404
https://doi.org/10.1158/1055-9965.23099404
Autor:
Chi-Chen Hong, Song Yao, Christine B. Ambrosone, Karen Hulme, Nancy Barone, Tracey L. O'Connor, Yali Zhang, Kristopher Attwood, Anthony George, Temara Cross
Supplementary Figure from Associations between Serum 25-Hydroxyvitamin D Levels and Health-Related Quality-of-Life Measures in Patients with Breast Cancer: A Longitudinal Study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ab3a184c9d08202e728c07ca2d866fe
https://doi.org/10.1158/1055-9965.23099410.v1
https://doi.org/10.1158/1055-9965.23099410.v1
Autor:
Chi-Chen Hong, Song Yao, Christine B. Ambrosone, Karen Hulme, Nancy Barone, Tracey L. O'Connor, Yali Zhang, Kristopher Attwood, Anthony George, Temara Cross
Background:Recent evidence suggests that vitamin D might lower breast cancer mortality. There is also growing interest in vitamin D's potential association with health-related quality-of-life (HRQoL). Associations between circulating 25-hydroxyvitami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c43d2be5b8dd8ba3d34a70915f323f3
https://doi.org/10.1158/1055-9965.c.6660331
https://doi.org/10.1158/1055-9965.c.6660331
Autor:
Adam Brufsky, Lauren Lenz, Anita Pudusseri, David Wright, Kashyap B. Patel, Brad T. Clifford, Tracey L. O'Connor, Sasha Strain, Fadi Kayali, Sarah Ratzel, Shelly Cummings, Ralf Kronenwett, Thomas Paul Slavin
Publikováno v:
Journal of Clinical Oncology. 40:537-537
537 Background: Current guidelines advise that individuals with estrogen receptor-positive (ER+) breast cancer (BC) undergo 5 years of endocrine therapy with consideration of up to 10 years of extended endocrine therapy (EET). The relative benefit of
Autor:
Jingran Ji, Can-Lan Sun, William Dale, Harvey Jay Cohen, Hyman B. Muss, Allison Magnuson, Tracey L. O'Connor, Rachel A. Freedman, Vani Katheria, Saro Armenian, Mina S. Sedrak
Publikováno v:
Journal of Clinical Oncology. 40:12042-12042
12042 Background: Although breast cancer and breast cancer chemotherapy (chemo) have been linked to accelerated functional decline, it is not well understood whether this decline is driven by cancer itself or the combination of cancer and chemo. Here
Autor:
Foluso O Ademuyiwa, Wiam Bshara, Kristopher Attwood, Carl Morrison, Stephen B Edge, Adam R Karpf, Smith A James, Christine B Ambrosone, Tracey L O'Connor, Ellis G Levine, Anthony Miliotto, Erika Ritter, Gerd Ritter, Sacha Gnjatic, Kunle Odunsi
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e38783 (2012)
NY-ESO-1 cancer testis (CT) antigen is an attractive candidate for immunotherapy as a result of its high immunogenicity. The aim of this study was to explore the potential for NY-ESO-1 antigen directed immunotherapy in triple negative breast cancer (
Externí odkaz:
https://doaj.org/article/ef744e6ac0f54ea59e960777fb415c60
Publikováno v:
Journal of psychosocial oncology. 29(4)
This study explored distress and coping strategies during and after breast cancer treatment. Open ended interview questions were used to explore stress and coping across the illness trajectory and during continuing care. With permission, 49 of the 50